ClinicalTrials.gg
RecruitingNCT07321600Updated Mar 3, 2026

Resisted Inspiratory Muscle Training Applied in Addition to PSSE-Schroth Exercises

An interventional study of Physiotherapeutic scoliosis-specific exercises (PSSE-Schroth) and PSSE-Schroth + Resistance IMT in Adolescence Idiopathic Scoliosis, sponsored by Hacettepe University. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 10 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-03-03.

Sponsored by Hacettepe University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jan 2026; still recruiting 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
10 Years to 18 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 15 studies in Scoliosis by Hacettepe University — 4 open to participants now, 4 under way, none of them phase 3. Scoliosis · Hacettepe University.

Planned enrollment
2nd of 11
45 · median 40
Started
2026
with 1 other
No phase
11 of 15
2 open now
Registered
13th of 15
by date

Among the 15 studies in Scoliosis by Hacettepe University, this one is the 2nd largest by planned enrollment of the 11 interventional ones that give a count, is one of 2 that started in 2026, is one of 11 with no phase, and was the 13th registered.

Scoliosis

660 studies on the registry are indexed under Scoliosis; 185 are open to participants now.

Browse Scoliosis studies →

Open to participants now

4 of the 15 studies in Scoliosis by Hacettepe University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 117 Scoliosis studies recruiting now, 23 (20%) set no upper age limit and 88 (75%) stop at 75 or younger; 98 take children under 18; 14 take healthy volunteers.

This study: 10 Years to 18 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Scoliosis by Hacettepe University, or all of them as a file.
02

Study summary

This prospective randomized controlled trial will evaluate whether adding resisted inspiratory muscle training (IMT) to Physiotherapeutic Scoliosis-Specific Exercises (PSSE)-Schroth exercises provides additional benefits on clinical outcomes in individuals with adolescent idiopathic scoliosis. Participants will be randomly assigned to either PSSE-Schroth plus IMT or PSSE-Schroth alone. Both groups will receive supervised exercise sessions three times per week for 8 weeks (24 sessions). Outcomes will be assessed before and after the intervention and will include clinical measures (e.g., Cobb angle, angle of trunk rotation, Posterior Trunk Symmetry Index, The Walter Reed Visual Assessment Scale), respiratory muscle performance (maximal inspiratory pressure/maximal expiratory pressure, six-minute walk test) and related physiological parameters, functional performance (balance, 3D kinematics, plantar pressure analysis, isokinetic strength), sleep quality, and health-related quality of life (Scoliosis Research Society- 22, Italian Spine Youth Quality of Life). The study is expected to enroll approximately 45 participants.

Read the detailed description

Adolescent idiopathic scoliosis (AIS) is a three-dimensional spinal deformity that may adversely affect thoracic volume, respiratory mechanics, postural symmetry, balance, functional capacity, and health-related quality of life. While physiotherapeutic scoliosis-specific exercises (PSSE), including the Schroth method, have demonstrated clinical benefit, the evidence regarding the added value of integrating structured inspiratory muscle training (IMT) with PSSE remains limited, particularly in studies using comprehensive physiological and biomechanical outcome sets.

This prospective, randomized controlled trial will investigate whether adding resisted IMT to a standardized PSSE-Schroth program provides additional improvements in clinical outcomes in adolescents with AIS.

Eligible participants will be females aged 10-18 years diagnosed with AIS, with Cobb angle between 10° and 45°, angle trunk rotation (ATR) ≥5°, and skeletal immaturity criteria consistent with Risser ≤3 and Sanders ≤4. Participants with non-idiopathic scoliosis, recent spine surgery/major trauma, contraindications to exercise, relevant systemic/neurological conditions, or recent participation in PSSE/IMT programs will be excluded.

Participants will be randomly allocated to one of two groups: (1) PSSE-Schroth plus resistance IMT or (2) PSSE-Schroth alone. Both groups will receive supervised sessions for 8 weeks, three times per week (total 24 sessions). The independent variable is the exercise protocol, and dependent variables include clinical measures.

The trial aims to provide a multidimensional evaluation of the potential additive effects of IMT when integrated with PSSE-Schroth, offering clinically relevant evidence to refine conservative rehabilitation strategies for AIS.

03

Conditions studied

  • Adolescence Idiopathic Scoliosis

Browse trials for

Keywords

  • Schroth
  • Physiotherapeutic scoliosis-specific exercises
  • Inspiratory muscle training
  • Adolescent Idiopathic Scoliosis
  • 3D motion analysis
  • plantar pressure
  • PSSE
04

Who can participate

Ages eligible
10 Years to 18 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Female adolescents aged 10-18 years.

Diagnosis of adolescent idiopathic scoliosis (AIS).

Cobb angle between 10° and 45°.

Angle trunk rotation (ATR) ≥ 5°.

Risser ≤ 3 and Sanders ≤ 4.

No scoliosis-related procedure within the last 6 months.

No to exercise.

Exclusion criteria

Exclusion Criteria:

Non-idiopathic scoliosis (neuromuscular, congenital, syndromic).

Inability to achieve ≥80% adherence/compliance.

History of spinal surgery or major trauma.

Cardiopulmonary diseases contraindicating exercise.

Neurological, rheumatological, vestibular, or systemic diseases.

Acute musculoskeletal injury or impaired skin integrity.

Participation in a regular PSSE-Schroth or IMT program within the last 3 months.

Intellectual disability or communication difficulties preventing protocol adherence.

Newly initiated brace treatment or high risk of non-compliance with brace management.

Lack of .

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
45 participants (estimated)

Study arms

  • Experimental
    PSSE-Schroth + Resistance IMT

    PSSE-Schroth session will last approximately 45-60 minutes. Exercises will be personalized (by the therapist) according to the individual's curve pattern; emphasis will be placed on the principles of auto-elongation, rotational angular breathing (RAB), derotation, stabilization, and symmetry. Positions will include semi-hanging, prone-on-knees, prone-on-stool, side-lying-on-T-side, side-lying-on-L-side, and supine-tension-with-poles. In addition to PSSE-Schroth exercises, resistance IMT will be applied. Training will be conducted using a threshold-loaded IMT device, maintaining Schroth postural alignment. The program will last eight weeks; three days a week, concurrently with PSSE sessions, each session lasting approximately 15-20 minutes.

    Other: Physiotherapeutic scoliosis-specific exercises (PSSE-Schroth) · Other: PSSE-Schroth + Resistance IMT

  • Active comparator
    PSSE-Schroth

    Participants will receive PSSE-Schroth exercises alone for 8 weeks, 3 sessions/week (24 sessions). PSSE-Schroth session will last approximately 45-60 minutes. Exercises will be personalized (by the therapist) according to the individual's curve pattern; emphasis will be placed on the principles of auto-elongation, rotational angular breathing (RAB), derotation, stabilization, and symmetry. Positions will include semi-hanging, prone-on-knees, prone-on-stool, side-lying-on-T-side, side-lying-on-L-side, and supine-tension-with-poles.

    Other: Physiotherapeutic scoliosis-specific exercises (PSSE-Schroth)

Interventions

  • OtherPhysiotherapeutic scoliosis-specific exercises (PSSE-Schroth)

    Participants will perform a standardized PSSE-Schroth exercise program under supervision. Sessions will be delivered three times per week for 8 weeks (total 24 sessions). Exercises will be individualized according to scoliosis pattern and clinical assessment

    Also known as: Schroth exercises, PSSE

  • OtherPSSE-Schroth + Resistance IMT

    Participants will receive threshold-loaded inspiratory muscle training in addition to PSSE-Schroth. IMT will be supervised and performed three times per week for 8 weeks, aligned with the exercise sessions. Training will be progressed according to individual tolerance and protocol targets

    Also known as: Resistance IMT

06

What researchers measure

Primary outcomes

  1. Six-Minute Walk Test

    The Six-Minute Walk Test (6MWT) is a tool designed to assess functional exercise capacity, with a particular focus on individuals suffering from cardiopulmonary conditions. The distance walked in six minutes on a flat, straight course, typically 30 metres long, is recorded. The distance measured reflects submaximal exercise capacity. The 6MWT is a valuable tool in the assessment of disease progression, the evaluation of rehabilitation outcomes, and the determination of treatment response.

    Time frame: Baseline and after 8 weeks (24 supervised sessions).

  2. Change in Cobb Angle

    Cobb angle will be measured on standard standing posteroanterior radiographs. The primary outcome is the change in Cobb angle from baseline to post-intervention.

    Time frame: Baseline and after 8 weeks (24 supervised sessions).

  3. Respiratory muscle strength - maximal inspiratory pressure (MIP)

    Maximal inspiratory pressure (cmH₂O) will be measured using a digital manometer. The primary outcome is the change in MIP from baseline to after the 8-week intervention, and the between-group difference in this change (PSSE-Schroth + resistance IMT vs PSSE-Schroth alone).

    Time frame: Baseline and Week 8 (end of 24 supervised sessions).

Secondary outcomes

  1. Angle of Trunk Rotation (ATR)

    Angle of trunk rotation will be measured using a Bunnell scoliometer during the forward bend test. The outcome will be reported as change from baseline to post-intervention and compared between groups.

    Time frame: Baseline and immediately after the 8-week intervention (24 sessions)

  2. Posterior Trunk Symmetry Index (POTSI)

    Posterior trunk symmetry will be evaluated using the Posterior Trunk Symmetry Index (POTSI). Change from baseline to post-intervention will be analyzed to assess the effect of adding inspiratory muscle training to PSSE-Schroth.

    Time frame: Baseline and immediately after the 8-week intervention.

  3. Walter Reed Visual Assessment Scale - Turkish version (WRVAS-TR)

    Perceived trunk deformity will be assessed with the Turkish version of the Walter Reed Visual Assessment Scale (WRVAS-TR). The outcome will be the change in total score from baseline to after the intervention.

    Time frame: Baseline and Week 8

  4. Health-related Quality of Life - SRS-22

    Health-related quality of life will be assessed using the Scoliosis Research Society-22 questionnaire. The outcome will be the change in total and domain scores from baseline to after the intervention.

    Time frame: Baseline and Week 8

  5. Health-related Quality of Life - ISYQOL

    Health-related quality of life will be assessed using the Italian Spine Youth Quality of Life (ISYQOL) questionnaire. Change in total score from baseline to after the 8-week intervention will be analyzed.

    Time frame: Baseline and Week 8

  6. Sleep quality (Pittsburgh Sleep Quality Index)

    Sleep quality will be measured using the Pittsburgh Sleep Quality Index (PSQI). The outcome will be the change in PSQI global score from baseline to after the intervention.

    Time frame: Baseline and Week 8

  7. Daytime sleepiness (Epworth Sleepiness Scale)

    Daytime sleepiness will be assessed using the Epworth Sleepiness Scale (adult or child/adolescent version, as appropriate). The outcome will be the change in total score from baseline to after the 8-week intervention and comparison between groups.

    Time frame: Baseline and Week 8

  8. Trunk muscle activation (surface EMG)

    Trunk muscle activation patterns will be evaluated using surface electromyography (sEMG) from selected trunk muscles during standardized postural or functional tasks. The outcome will be the change in normalized EMG activity from baseline to after the 8-week intervention

    Time frame: Baseline and Week 8

  9. Spinal and pelvic kinematics (3D motion analysis)

    Three-dimensional motion analysis will be used to quantify spinal and pelvic kinematics during standardized tasks. The outcome will be the change in relevant kinematic parameters from baseline to after the 8-week intervention.

    Time frame: Baseline and Week 8

  10. Plantar pressure distribution (baropodometric analysis)

    Plantar pressure distribution and load symmetry will be assessed using a baropodometric platform. The outcome will be the change in plantar pressure variables (e.g., forefoot-rearfoot loading and left-right symmetry) from baseline to after the 8-week intervention.

    Time frame: Baseline and Week 8

  11. Knee muscle strength (isokinetic quadriceps and hamstrings)

    Knee extensor (quadriceps) and flexor (hamstring) muscle strength will be measured using an isokinetic dynamometer during concentric knee flexion and extension. The outcome will be the change in peak torque (normalized to body mass) from baseline to after the 8-week intervention.

    Time frame: Baseline and Week 8

  12. Postural Control Assessment

    Individuals' postural control in static-eyes open, static-eyes closed, and dynamic positions will be measured using the Korebalance® System. The Korebalance® System is a computerised platform that combines balance assessment with exercise, providing a technologically advanced solution for balance-related concerns.

    Time frame: Baseline and after 8 weeks (24 supervised sessions).

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — IPD will not be shared due to participant privacy considerations and the inclusion of minors.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Dec 2026, 11 months after the start.

Of 224 non-industry interventional studies with no phase under Scoliosis, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 58. This study's planned 11 months is below that.

Counting every sponsor, half of 234 studies reached it within 22 months; a quarter within 8 and three quarters within 60.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 23, 2025
First posted
Jan 7, 2026
StartActual
Jan 2, 2026
Primary completionEst.
Dec 2, 2026
CompletionEst.
Mar 2, 2027
Last update
Mar 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07321600
Responsible party
Caner Karartı (Caner KARARTI, Assoc. Prof, Hacettepe University) — Principal investigator
First posted
Jan 7, 2026
Start date
Jan 2, 2026
Primary completion
Dec 2, 2026 (estimated)
Completion
Mar 2, 2027 (estimated)
Last update
Mar 3, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion